Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Warby Parker Inc

Healthcare US WRBY

25.54USD
0.26(1.03%)

Last update at 2026-03-10T20:00:00Z

Day Range

24.7926.20
LowHigh

52 Week Range

9.5017.88
LowHigh

Fundamentals

  • Previous Close 25.28
  • Market Cap1617.55M
  • Volume2118903
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-35.03600M
  • Revenue TTM654.40M
  • Revenue Per Share TTM5.61
  • Gross Profit TTM 341.06M
  • Diluted EPS TTM-0.56

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -109.89600M -144.00800M -55.72900M 0.28M
Minority interest - - - -
Net income -110.39300M -144.27100M -55.91900M 0.00000M
Selling general administrative 452.26M 461.41M 287.57M 224.77M
Selling and marketing expenses - - - -
Gross profit 341.06M 317.75M 231.94M 223.11M
Reconciled depreciation 31.86M 21.87M 18.38M 14.52M
Ebit -111.20300M -143.66100M -55.63200M -1.66300M
Ebitda -79.33900M -121.79300M -37.25500M 12.85M
Depreciation and amortization 31.86M 21.87M 18.38M 14.52M
Non operating income net other - -0.34700M - -
Operating income -111.20300M -143.66100M -55.63200M -1.66300M
Other operating expenses 709.32M 684.46M 449.35M 372.13M
Interest expense -1.30700M 0.35M 0.10M 1.94M
Tax provision 0.50M 0.26M 0.19M 0.28M
Interest income - - - -
Net interest income 1.31M -0.34700M -0.09700M 1.94M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.50M 0.26M 0.19M 0.28M
Total revenue 598.11M 540.80M 393.72M 370.46M
Total operating expenses 452.26M 461.41M 287.57M 224.77M
Cost of revenue 257.05M 223.05M 161.78M 147.35M
Total other income expense net 1.31M -0.34700M -0.09700M 1.94M
Discontinued operations - - - -
Net income from continuing ops -110.39300M -144.27100M -55.91900M 0.00000M
Net income applicable to common shares -110.39300M -157.40800M -55.91900M -57.53700M
Preferred stock and other adjustments - 13.14M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 568.71M 440.65M 444.75M 175.86M
Intangible assets - - - -
Earning assets - - - -
Other current assets 15.70M 13.48M 6.78M 6.71M
Total liab 282.06M 154.65M 136.34M 102.46M
Total stockholder equity 286.65M 286.00M 308.41M 73.40M
Deferred long term liab 8.20M 36.54M - -
Other current liab 60.59M 4.30M 3.72M 2.96M
Common stock 0.01M 0.01M 0.00500M 0.00500M
Capital stock 0.01M 0.01M 506.51M 262.85M
Retained earnings -603.63400M -493.24100M -325.39000M -269.47100M
Other liab 1.67M 36.54M 31.01M 26.59M
Good will - - - -
Other assets 8.50M 0.47M 0.28M 0.28M
Cash 208.59M 256.42M 314.08M 55.42M
Cash and equivalents - - - -
Total current liabilities 129.56M 118.10M 105.33M 75.87M
Current deferred revenue 25.63M 22.07M 26.55M 19.25M
Net debt -35.20700M -256.41600M -314.08500M -55.42400M
Short term debt 22.55M 60.84M 34.27M 16.35M
Short long term debt - - - -
Short long term debt total 173.38M - - -
Other stockholder equity 890.91M 338.57M 127.18M 79.99M
Property plant equipment 254.34M 112.19M 80.93M 80.19M
Total current assets 294.57M 327.98M 359.93M 91.68M
Long term investments - - - -
Net tangible assets 275.35M 286.00M -201.69700M -193.15300M
Short term investments - - - -
Net receivables 1.44M 0.99M 0.60M 1.12M
Long term debt - - - -
Inventory 68.85M 57.09M 38.47M 28.44M
Accounts payable 20.79M 30.89M 40.79M 37.31M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income -0.64700M 0.02M 0.11M 0.02M
Additional paid in capital - - - -
Common stock total equity - 0.01M - -
Preferred stock total equity - - - -
Retained earnings total equity - -493.24100M - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 8.50M 0.47M 0.28M 0.28M
Deferred long term asset charges - - - -
Non current assets total 274.14M 112.67M 84.82M 84.17M
Capital lease obligations 173.38M - - -
Long term debt total - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -60.18100M -48.51300M -20.07000M -32.63200M
Change to liabilities -4.36000M -2.66200M 13.19M 7.62M
Total cashflows from investing activities -60.18100M -48.51300M -20.07000M -32.63200M
Net borrowings 0.09M 31.61M 0.94M 0.59M
Total cash from financing activities 3.29M 23.00M 245.94M -83.36200M
Change to operating activities 2.06M 10.11M 21.70M 4.01M
Net income -110.39300M -144.27100M -55.91900M 0.00000M
Change in cash -47.83100M -57.66900M 258.66M -94.36300M
Begin period cash flow 256.42M 314.08M 55.42M 149.79M
End period cash flow 208.59M 256.42M 314.08M 55.42M
Total cash from operating activities 10.37M -31.99400M 32.76M 21.39M
Issuance of capital stock 2.74M 0.00000M 243.66M 0.00000M
Depreciation 31.86M 21.87M 18.38M 14.52M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory -11.79400M -18.62400M -10.02000M -12.61000M
Change to account receivables -0.45100M -0.39200M 0.52M -0.64400M
Sale purchase of stock 0.00000M -8.08500M 0.00000M -79.47400M
Other cashflows from financing activities 0.55M 31.08M 276.84M -3.88800M
Change to netincome 103.45M 114.91M 44.91M 8.50M
Capital expenditures 60.18M 48.51M 20.07M 32.63M
Change receivables - -0.39200M - -
Cash flows other operating - -2.81800M - -
Exchange rate changes - - - -
Cash and cash equivalents changes - -57.50800M - -
Change in working capital -14.55000M -24.49600M 25.39M -1.62100M
Stock based compensation 98.03M 107.15M 44.91M 8.50M
Other non cash items 5.42M 7.76M - -
Free cash flow -49.81100M -80.50700M 12.69M -11.23800M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
WRBY
Warby Parker Inc		 0.26 1.03% 25.54 - 62.11 2.27 4.88 2.20 -41.168
ISRG
Intuitive Surgical Inc		 -7.71 1.56% 485.85 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA		 -0.25 0.20% 122.50 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme		 4.90 2.00% 249.71 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 -1.58 0.95% 163.88 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

View All

Profile

Warby Parker Inc. provides eyewear products. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Warby Parker Inc

233 Spring Street, New York, NY, United States, 10013

Key Executives

Name Title Year Born
Mr. Neil Harris Blumenthal Co-Founder, Pres, Co-CEO & Co-Chair 1981
Mr. David Abraham Gilboa Co-Founder, Co-CEO & Co-Chair 1982
Mr. Andrew M. Hunt Co-Founder & Independent Director NA
Mr. Jeff Raider Co-Founder & Independent Director NA
Mr. Steve Miller Sr. VP & CFO NA
Ms. Stephanie Pullings Hart Sr. VP of Operations 1974
Mr. Jeffrey Saunders Sr. VP & CTO NA
Ms. Tina Romani VP of Investor Relations NA
Ms. Lori Krauss Sr. VP & Chief Marketing Officer NA
Ms. Chelsea Kaden Sr. VP & Head of People NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.